{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:39:45Z","timestamp":1790080785046,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s41999-019-00175-3","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T15:04:07Z","timestamp":1552662247000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prescription and deprescription of medications for older adults receiving palliative care during the last 3\u00a0months of life: a single-center retrospective cohort study"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-1246","authenticated-orcid":false,"given":"Barbara","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-8610","authenticated-orcid":false,"given":"Lucas","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Papon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-0359","authenticated-orcid":false,"given":"Marie-Laure","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"927\u2013936","key":"175_CR1","first-page":"e9","volume":"130","author":"L Morin","year":"2017","unstructured":"Morin L, Vetrano DL, Rizzuto D, Calder\u00f3n-Larra\u00f1aga A, Fastbom J, Johnell K (2017) Choosing wisely? Measuring the burden of medications in older adults near the end of life: Nationwide, longitudinal cohort study. Am J Med 130(927\u2013936):e9","journal-title":"Am J Med"},{"key":"175_CR2","doi-asserted-by":"publisher","first-page":"178e2","DOI":"10.1016\/j.jpainsymman.2015.09.003","volume":"51","author":"MJ McNeil","year":"2016","unstructured":"McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP (2016) The burden of polypharmacy in patients near the end of life. J Pain Symptom Manag 51:178e2\u2013183e2","journal-title":"J Pain Symptom Manag"},{"key":"175_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jpainsymman.2015.12.325","volume":"51","author":"NJ Noortgate Van Den","year":"2016","unstructured":"Van Den Noortgate NJ, Verhofstede R, Cohen J, Piers RD, Deliens L, Smets T (2016) Prescription and deprescription of medication during the last 48 hours of life: Multicenter study in 23 acute geriatric wards in Flanders Belgium. J Pain Symptom Manag 51:1020\u20131026","journal-title":"J Pain Symptom Manag"},{"key":"175_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jamda.2016.01.015","volume":"17","author":"RT Nordennen Van","year":"2016","unstructured":"Van Nordennen RT, Lavrijsen JC, Heesterbeek MJ, Vissers KC, Koopmans RT (2016) Changes in prescribed drugs between admission and the end of life in patients admitted to palliative care facilities. J Am Med Dir Assoc 17:514\u2013518","journal-title":"J Am Med Dir Assoc"},{"key":"175_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1532-5415.2006.00889.x","volume":"54","author":"MA Steinman","year":"2006","unstructured":"Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54:1516\u20131523","journal-title":"J Am Geriatr Soc"},{"key":"175_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/17425255.2016.1179281","volume":"12","author":"LG Franken","year":"2016","unstructured":"Franken LG, De Winter BC, Van Esch HJ et al (2016) Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol 12:669\u2013680","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"175_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/bmjspcare-2015-000941","volume":"7","author":"A Todd","year":"2017","unstructured":"Todd A, Nazar H, Inga A, Pearson SA, Lindsey L, Holmes H (2017) Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care 7:113\u2013121","journal-title":"BMJ Support Palliat Care"},{"key":"175_CR8","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00520-010-0947-1","volume":"19","author":"A Fede","year":"2011","unstructured":"Fede A, Miranda M, Antonangelo D et al (2011) Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 19:1313\u20131318","journal-title":"Support Care Cancer"},{"key":"175_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1001\/jamainternmed.2016.7714","volume":"177","author":"J Tjia","year":"2017","unstructured":"Tjia J, Lapane K (2017) Guideline-Based Prescribing in Frail Elderly Patients. JAMA Intern Med 177:262\u2013263","journal-title":"JAMA Intern Med"},{"key":"175_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00520-008-0541-y","volume":"17","author":"RP Riechelmann","year":"2009","unstructured":"Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17:745\u2013748","journal-title":"Support Care Cancer"},{"key":"175_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4143\/crt.2013.45.3.220","volume":"45","author":"HR Lee","year":"2013","unstructured":"Lee HR, Yi SY, Kim DY (2013) Evaluation of prescribing medications for terminal cancer patients near death: essential or futile. Cancer Res Treat 45:220\u2013225","journal-title":"Cancer Res Treat"},{"key":"175_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00520-014-2322-0","volume":"23","author":"J Lindsay","year":"2015","unstructured":"Lindsay J, Dooley M, Martin J et al (2015) The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019. Support Care Cancer 23:71\u201378","journal-title":"Support Care Cancer"},{"key":"175_CR13","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1532-5415.2008.01741.x","volume":"56","author":"HM Holmes","year":"2008","unstructured":"Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W (2008) Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 56:1306\u20131311","journal-title":"J Am Geriatr Soc"},{"key":"175_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jamainternmed.2014.4103","volume":"174","author":"J Tjia","year":"2014","unstructured":"Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL (2014) Use of medications of questionable benefit in advanced dementia. JAMA Intern Med 174:1763","journal-title":"JAMA Intern Med"},{"key":"175_CR15","doi-asserted-by":"publisher","first-page":"551.e1","DOI":"10.1016\/j.jamda.2017.02.021","volume":"18","author":"L Morin","year":"2017","unstructured":"Morin L, Vetrano DL, Grande G, Fratiglioni L, Fastbom J, Johnell K (2017) Use of medications of questionable benefit during the last year of life of older adults with dementia. J Am Med Dir Assoc 18:551.e1\u2013551.e7","journal-title":"J Am Med Dir Assoc"},{"key":"175_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/jgs.14844","volume":"65","author":"JN Matlow","year":"2017","unstructured":"Matlow JN, Bronskill SE, Gruneir A et al (2017) Use of medications of questionable benefit at the end of life in nursing home residents with advanced dementia. J Am Geriatr Soc 65:1535\u20131542","journal-title":"J Am Geriatr Soc"},{"key":"175_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjopharm.2009.02.001","volume":"7","author":"EM Suhrie","year":"2009","unstructured":"Suhrie EM, Hanlon JT, Jaffe EJ, Sevick MA, Ruby CM, Aspinall SL (2009) Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother 7:20\u201325","journal-title":"Am J Geriatr Pharmacother"},{"key":"175_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1179\/096992609X12455871937549","volume":"17","author":"MY Lim","year":"2009","unstructured":"Lim MY (2009) Audit on the management of diabetes in terminally-ill medical patients. Prog Palliat Care 17:302\u2013306","journal-title":"Prog Palliat Care"},{"key":"175_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11096-014-9932-y","volume":"36","author":"A Todd","year":"2014","unstructured":"Todd A, Nazar H, Pearson S, Andrew L, Baker L, Husband A (2014) Inappropriate prescribing in patients accessing specialist palliative day care services. Int J Clin Pharm 36:535\u2013543","journal-title":"Int J Clin Pharm"},{"key":"175_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40266-014-0183-3","volume":"31","author":"M Barcel\u00f3","year":"2014","unstructured":"Barcel\u00f3 M, Torres O, Ruiz D, Casademont J (2014) Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization. Drugs Aging 31:541\u2013546","journal-title":"Drugs Aging"},{"key":"175_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s11096-017-0518-3","volume":"39","author":"D Sevilla-S\u00e1nchez","year":"2017","unstructured":"Sevilla-S\u00e1nchez D, Molist-Brunet N, Ambl\u00e0s-Novellas J, Espaulella-Panicot J, Codina-Jan\u00e9 C (2017) Potentially inappropriate medication at hospital admission in patients with palliative care needs. Int J Clin Pharm 39:1018\u20131030","journal-title":"Int J Clin Pharm"},{"key":"175_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s41999-018-0073-z","volume":"9","author":"D Sevilla-S\u00e1nchez","year":"2018","unstructured":"Sevilla-S\u00e1nchez D, Molist-Brunet N, Espaulella-Panicot J et al (2018) Potentially inappropriate medication in palliative care patients according to STOPP-Frail criteria. Eur Geriatr Med 9:543\u2013550","journal-title":"Eur Geriatr Med"},{"key":"175_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/17843286.2017.1410606","volume":"73","author":"P Pype","year":"2018","unstructured":"Pype P, Mertens F, Helewaut F, D\u2019Hulster B, De Sutter A (2018) Potentially inappropriate medication in primary care at the end of life: a mixed-method study. Acta Clin Belg 73:213\u2013219","journal-title":"Acta Clin Belg"},{"key":"175_CR24","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3389\/fphar.2017.00990","volume":"8","author":"HG Meer Van der","year":"2018","unstructured":"Van der Meer HG, Taxis K, Pont LG (2018) Changes in prescribing symptomatic and preventive medications in the last year of life in older nursing home residents. Front Pharmacol 8:990","journal-title":"Front Pharmacol"},{"key":"175_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ageing\/afy054","volume":"47","author":"D Curtin","year":"2018","unstructured":"Curtin D, O\u2019Mahony D, Gallagher P (2018) Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing 47:749\u2013753","journal-title":"Age Ageing"},{"issue":"2","key":"175_CR26","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1111\/ajag.12220","volume":"35","author":"CP Heppenstall","year":"2016","unstructured":"Heppenstall CP, Broad JB, Boyd M et al (2016) Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care: medication use in residential aged care. Austral J Ageing 35(2):E18\u201324","journal-title":"Austral J Ageing"},{"key":"175_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/annonc\/mdl373","volume":"18","author":"L Lima De","year":"2007","unstructured":"De Lima L (2007) International association for hospice and palliative care list of essential medicines for palliative care. Ann Oncol 18:395\u2013399","journal-title":"Ann Oncol"},{"key":"175_CR28","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (2002) Soins palliatifs : sp\u00e9cificit\u00e9 d\u2019utilisation des m\u00e9dicaments courants hors antalgiques. \n                    https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/a7335ff84e05050e5dfccc7a164c885b.pdf\n                    \n                   Accessed 31 Jan 2017"},{"key":"175_CR29","unstructured":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019Evaluation en Sant\u00e9 (2002) Recommandations pour la pratique clinique\u00a0:modalit\u00e9s de prise en charge de l\u2019adulte n\u00e9cessitant des soins palliatifs. \n                    https:\/\/www.hassante.fr\/portail\/upload\/docs\/application\/pdf\/txt_soins_palliatifs_recommandations_finales_mise_en_ligne.pdf\n                    \n                  . Accessed 20 Feb 2017"},{"key":"175_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1532-5415.2007.01124.x","volume":"55","author":"DC Currow","year":"2007","unstructured":"Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches: Polypharmacy in palliative care. J Am Geriatr Soc 55:590\u2013595","journal-title":"J Am Geriatr Soc"},{"key":"175_CR31","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1111\/jgs.13795","volume":"63","author":"LL Dwyer","year":"2015","unstructured":"Dwyer LL, Lau DT, Shega JW (2015) Medications that older adults in hospice care in the United States take, 2007. J Am Geriatr Soc 63:2282\u20132289","journal-title":"J Am Geriatr Soc"},{"key":"175_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11096-015-0094-3","volume":"37","author":"AD Masman","year":"2015","unstructured":"Masman AD, van Dijk M, Tibboel D, Baar FP, Math\u00f4t RA (2015) Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm 37:767\u2013775","journal-title":"Int J Clin Pharm"},{"key":"175_CR33","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.rmed.2013.06.003","volume":"107","author":"K Beernaert","year":"2013","unstructured":"Beernaert K, Cohen J, Deliens L et al (2013) Referral to palliative care in COPD and other chronic diseases: a population-based Study. Respir Med 107:1731\u20131739","journal-title":"Respir Med"},{"key":"175_CR34","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1001\/archinte.168.16.1747","volume":"168","author":"L Block Van den","year":"2008","unstructured":"Van den Block L, Deschepper R, Bossuyt N et al (2008) Care for patients in the last months of life: the Belgian sentinel network monitoring end-of-Life Care study. Arch Intern Med 168:1747\u20131754","journal-title":"Arch Intern Med"},{"key":"175_CR35","doi-asserted-by":"publisher","first-page":"j878","DOI":"10.1136\/bmj.j878","volume":"356","author":"SA Murray","year":"2017","unstructured":"Murray SA, Kendall M, Mitchell G, Moine S, Ambl\u00e0s-Novellas J, Boyd K (2017) Palliative care from diagnosis to death. BMJ 356:j878","journal-title":"BMJ"},{"key":"175_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non\u2013small-cell lung cancer. N Engl J Med 363:733\u2013742","journal-title":"N Engl J Med"},{"key":"175_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/15360288.2014.911801","volume":"28","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014) Strengthening of palliative care as a component of integrated treatment throughout the life course. J Pain Palliat Care Pharmacother 28:130\u2013134","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"175_CR38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of \u00ab deprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80:1254\u20131268","journal-title":"Br J Clin Pharmacol"},{"key":"175_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH Jr et al (2015) Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 175:691\u2013700","journal-title":"JAMA Intern Med"},{"key":"175_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ageing\/afx138","volume":"46","author":"AH Lavan","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, O\u2019Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail Adults with Limited Life Expectancy): consensus validation. Age Ageing 46:600\u2013607","journal-title":"Age Ageing"},{"key":"175_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2507-4","author":"L Morin","year":"2018","unstructured":"Morin L, Laroche ML, Vetrano DL, Fastbom J, Johnell K (2018) Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. \n                    https:\/\/doi.org\/10.1007\/s00228-018-2507-4","journal-title":"Eur J Clin Pharmacol"},{"key":"175_CR42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s11096-015-0148-6","volume":"37","author":"A Todd","year":"2015","unstructured":"Todd A, Holmes HM (2015) Recommendations to support deprescribing medications late in life. Int J Clin Pharm 37:678\u2013681","journal-title":"Int J Clin Pharm"},{"key":"175_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40266-014-0182-4","volume":"31","author":"RT Nordennen Van","year":"2014","unstructured":"Van Nordennen RT, Lavrijsen JC, Vissers KC, Koopmans RT (2014) Decision making about change of medication for comorbid disease at the end of life: an integrative review. Drugs Aging 31:501\u2013512","journal-title":"Drugs Aging"},{"key":"175_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1049909110361244","volume":"27","author":"QNH Tran","year":"2010","unstructured":"Tran QNH (2010) Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer. Am J Hosp Palliat Care 27:416\u2013419","journal-title":"Am J Hosp Palliat Care"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-019-00175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s41999-019-00175-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-019-00175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:27:28Z","timestamp":1584145648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s41999-019-00175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1007\/s41999-019-00175-3","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}